Compare Align Technology, Inc. (ALGN) vs Philip Morris International Inc. (PM) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Align Technology, Inc. vs Philip Morris International Inc. — how do they compare? Align Technology, Inc. trades at $179.45 (market cap $12.86B), while Philip Morris International Inc. trades at $182.02 (market cap $283.07B). The key difference: Philip Morris International Inc. is far larger — about 22× Align Technology, Inc.'s market cap, and Philip Morris International Inc. pays a 3.24% dividend while Align Technology, Inc. pays none. Which is the better fit depends on your goals.
| ALGN | PM | |
|---|---|---|
Market Cap | $12.86B | $283.07B |
Sector | Health | Consumer Staples |
52-Week High | $207.19 | $191.86 |
52-Week Low | $124.88 | $144.33 |
Enterprise Value | $11.92B | $329.56B |
Dividend Yield | — | 3.24% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
Philip Morris International (PM) trades at $181.62, up 0.25% today, near the analyst consensus price target of $194. The stock shows a bullish technical trend with support at $179 and resistance at $185. Recent Q1 2026 earnings beat expectations at $1.96 EPS versus $1.86, though Q4 2025 missed. Revenue grew to $40.65B in 2025 with a strong net margin of 26.74%. The company announced a $1.47 dividend payable July 20, 2026, but cut its 2026 profit forecast due to a $500M impairment and cost pressures.
Outlook remains positive with 68% analyst buy ratings, but risks include rising illicit cigarette trade in Europe, currency volatility, and consumer spending constraints. The stock offers value with a P/E of 25.57 and stable cash flows, though high debt levels and regulatory challenges require monitoring for sustained growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Align Technology, Inc.
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →About Philip Morris International Inc.
Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Read more on PM →
